NFKB1 and acute kidney injury: Glycyrrhizic acid, 18β-glycyrrhetinic acid, hypericin, and eriodictyol reduce AKI by inhibiting the cisplatin-induced phosphorylation of NF-κB and upregulating the expression of nuclear factor erythroid 2 (NFE2)-related factor 2 (NRF2) and HO-1 [88–90].